PDL BioPharma (PDLI)

Add to Watchlists
Create an Alert
7.90 +0.20  +2.60% NASDAQ Dec 18, 8:00PM BATS Real time Currency in USD
View Full Chart
PDLI Price Chart
View All Events

PDLI Events

Date Type Description
12/03/2014 Dividends Amount: 0.15, Declared Date: Jan 30 2014, Pay Date: Dec 12 2014
11/10/2014 Misc PDL BioPharma Inc 3Q2014 Earning Conference Call
11/10/2014 Earnings PDL BioPharma Inc 3Q2014 Earning Results
09/03/2014 Dividends Amount: 0.15, Declared Date: Jan 30 2014, Pay Date: Sep 12 2014
08/11/2014 16:30 EDT Misc PDL BioPharma Inc 2Q2014 Earning Conference Call
08/11/2014 Earnings PDL BioPharma Inc 2Q2014 Earning Result
06/03/2014 Dividends Amount: 0.15, Declared Date: Jan 30 2014, Pay Date: Jun 12 2014
05/12/2014 16:30 EDT Misc PDL BioPharma Inc 1Q2014 Earning Conference Call
05/12/2014 Earnings PDL BioPharma Inc 1Q2014 Earning Result
03/12/2014 Misc PDL Biopharma Announces 2014 Regular Quarterly Dividends
View All Performance Charts

PDLI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). PDL BioPharma is up 0.80% over the last year vs S&P 500 Total Return up 16.21%, Roche Holding up 13.68%, and Biogen Idec up 26.03%.

Get Quote for

PDF Report for PDLI

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download PDLI Pro Report PDF
Advertisement

Portfolio Strategies Featuring PDLI

Did PDL BioPharma make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

PDLI Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.pdl.com
  • IR Website: http://investor.pdl.com/
  • HQ Country: United States
  • HQ State/Province: Nevada
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: September 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

PDL BioPharma, Inc., is engaged in the discovery of a new generation of targeted treatments for cancer & immunologic diseases. It focuses on intellectual property asset management, investing in new royalty bearing assets & maximizing value of its patent.

PDLI Excel Add-In Codes

  • Name: =YCI("PDLI","name")
  • Description: =YCI("PDLI","description")
  • Sector: =YCI("PDLI","sector")
  • Industry: =YCI("PDLI","industry")
  • Est. Current Fiscal Year End: =YCI("PDLI","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.